UPDATE
: Monday, December 9, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Lilly's Verzenio extends life for women with advanced breast cancer
by Lee Han-soo
2019-10-04 16:15
Eisai’s hepatocellular carcinoma treatment Lenvima to get insurance benefit
by Lee Han-soo
2019-10-02 16:10
CDK4/6 inhibitor+fulvestrant combo nears getting benefit
by Kim Yun-mi
2019-10-02 16:03
Daewoong's EU partner wins sales approval for BTX
by Lee Han-soo
2019-10-02 14:51
Daewoong's reaffirms drug-marketing power with Daiichi Sankyo's NOAC treatment
by Lee Han-soo
2019-10-01 16:43
라인
Drugmakers’ illegal rebates down, support for doctors up
by Kwak Sung-sun
2019-10-01 13:49
Crystal Genomics confirms efficacy of epigenetics-based pulmonary fibrosis treatment
by Lee Han-soo
2019-10-01 11:21
‘Merck Korea unilaterally lays off employees’
by Kim Yun-mi
2019-10-01 11:09
Allergan to compensate breast implant recipients for damage
by Lee Hye-seon
2019-09-30 15:33
Ranitidine recall taking heavy toll on pharmaceuticals
by Jeong Sae-im
2019-09-30 15:16
라인
Sale of Novartis’ conjunctivitis drug Pataday banned for 3 months
by Lee Hye-seon
2019-09-30 11:25
Investor trust in bio-industrialists sank due to latter’s unethical acts
by Lee Han-soo
2019-09-27 15:11
Genexine sets up joint firm in Thailand
by Lee Han-soo
2019-09-26 17:00
[Analysis] Successive failures throw Korean bioindustry's drug-developing ability into question
by Lee Han-soo
2019-09-26 15:39
Pfizer’s leukemia therapy Besponsa to get insurance benefit
by Kim Yun-mi
2019-09-26 11:26
라인
'Xtandi emerges as convenient treatment option for prostate cancer patients'
by Lee Han-soo
2019-09-25 17:39
Huons, Lipac Oncology to co-develop bladder cancer treatment
by Lee Han-soo
2019-09-25 11:18
AstraZeneca releases detailed results of P3 trial of SGLT2 inhibitor
by Lee Han-soo
2019-09-24 18:08
Qurient enrolls patients for trials of atopy treatment
by Lee Han-soo
2019-09-24 17:00
Hanmi’s US partner to unveil results of anticancer drug study
by Lee Han-soo
2019-09-24 17:00
-
1
2
3
4
5
6
7
8
9
10
다음
-
Korea selected as 'Medical Tourism Destination of the Year'
AbbVie's releases new data for chronic lymphocytic leukemia treatment
Japan OKs Medipost's P2 trial of stem cell-serviced osteoarthritis treatment
Genematrix wins CE certification for respiratory disease virus detection kit
Korea selected as 'Medical Tourism Destination of the Year'
AbbVie's releases new data for chronic lymphocytic leukemia treatment
Japan OKs Medipost's P2 trial of stem cell-serviced osteoarthritis treatment
Genematrix wins CE certification for respiratory disease virus detection kit
여백
Most viewed
1
Technology developed to detect inflammatory disorders early
2
'Insulin is safe, natural replacement therapy for diabetic patients'
3
Roche Diabetes Care stresses ‘integrated personalized diabetes management’
4
Samyang Biopharm’s US subsidiary to work on new immunotherapy
5
Swedish researchers divide Type 2 diabetes into 5 subgroups
6
Ildong signs co-promotion contract with GSK Consumer Healthcare
7
Korean patient with rare breast cancer to sue Allergan in US
8
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
9
Korea exports health insurance system to Bahrain
10
Quick test for meningitis unavailable due to low reimbursement
여백
Opinion
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
[Reporter’s Notebook] SillaJen should be ashamed of itself
여백
Back to Top